ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3,2,Headache,Headaches NEC,Headaches,Nerv,N
4,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
9,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
9,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
9,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,6,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,7,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
9,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
9,10,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
9,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
10,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
15,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
15,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
17,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
23,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
23,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
23,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,5,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
23,6,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
23,9,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,10,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
23,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
23,13,Sinus rhythm,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
24,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
24,2,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
24,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
24,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
25,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
25,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,6,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
25,7,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
26,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
27,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
27,2,Thyroxine free decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
28,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
28,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
29,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
29,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
30,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
30,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
31,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
31,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
32,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
32,3,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
32,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
32,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
32,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
33,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
34,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
34,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
35,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
35,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
36,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
36,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
37,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
39,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
39,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
41,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
41,2,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
42,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
43,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
43,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
44,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
44,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
45,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
46,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
46,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
46,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
47,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
48,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
49,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
50,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
51,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
51,2,Electrocardiogram ST segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
51,3,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
51,4,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
52,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
52,2,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
53,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
54,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
55,1,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
56,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
57,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
58,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
59,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
60,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
61,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
62,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
63,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
64,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
65,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,1,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
67,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
67,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
68,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
69,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
69,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
70,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
71,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
71,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
71,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
72,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
72,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,3,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
73,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
73,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
73,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
74,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
75,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
75,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
75,3,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
76,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
76,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
76,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,4,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
76,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
76,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,7,Red blood cell sedimentation rate decreased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
77,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
77,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
78,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
78,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
79,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
80,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
81,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
81,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
82,1,Thyroid cyst,Thyroid neoplasms,Thyroid gland disorders,Endo,N
83,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
85,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
86,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
87,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
88,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
89,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
89,2,CSF test abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
89,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
89,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
89,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,6,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
89,7,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
89,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
89,9,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
89,10,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,11,Varicella virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
89,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
90,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
91,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
93,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
93,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
93,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
93,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
93,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
94,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
94,3,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
94,4,Blood folate increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
94,5,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
94,6,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
94,7,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
94,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
94,10,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,11,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,12,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
94,13,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
95,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
95,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
95,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
95,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
95,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
96,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
96,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
97,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
97,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
97,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
97,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
97,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
97,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
97,7,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
97,8,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
97,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
97,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
97,11,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
97,12,Headache,Headaches NEC,Headaches,Nerv,N
97,13,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
97,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
97,15,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
97,16,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
97,17,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
97,18,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
97,19,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
97,21,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
97,22,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
97,23,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,24,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
97,25,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
98,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
99,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
99,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
100,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
100,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
101,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
101,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
101,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
102,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
102,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
103,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
103,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
103,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
105,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
105,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
105,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
106,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
106,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
106,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
106,6,Headache,Headaches NEC,Headaches,Nerv,N
106,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
106,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
106,10,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
106,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
106,12,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
106,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
107,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
107,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
108,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
109,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
110,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
110,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
110,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
111,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
112,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
113,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
113,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
113,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
113,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
114,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
115,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
115,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
116,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
117,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
117,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
117,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
117,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
118,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
119,1,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
120,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
120,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
120,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
120,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
120,5,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
120,6,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
120,7,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
120,8,Middle cerebral artery stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
120,9,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
120,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
120,11,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
120,12,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
120,13,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
121,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
122,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
122,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
122,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
123,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
123,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
126,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
126,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
127,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
127,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
127,3,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
127,4,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
128,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
128,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
128,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
128,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
128,5,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
128,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
129,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
130,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
130,3,Total lung capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
131,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
132,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
132,2,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
132,3,Blood chloride increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
132,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
132,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
132,6,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,9,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,10,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
132,11,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
132,12,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
132,13,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
133,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
133,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
134,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
134,2,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
134,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
134,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
134,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
135,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
136,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
137,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
137,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
138,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
139,1,Bronchogenic cyst,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
140,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
140,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
140,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
140,6,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
140,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
140,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
141,1,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
141,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
141,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
142,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
142,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
143,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
143,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
144,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
145,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
145,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
146,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
146,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
146,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,5,Mean platelet volume decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
146,6,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
146,9,T-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
147,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
147,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
148,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
148,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
148,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
148,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
148,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
148,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
148,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
149,1,Menometrorrhagia,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
149,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
149,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
151,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
151,2,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
152,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
152,2,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
153,1,Urticarial vasculitis,Urticarias,Angioedema and urticaria,Skin,N
154,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
156,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
156,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
157,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
157,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
158,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
159,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
159,2,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
160,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
161,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
162,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
163,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
163,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,3,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,1,Headache,Headaches NEC,Headaches,Nerv,N
164,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
164,3,Migraine,Migraine headaches,Headaches,Nerv,N
164,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
167,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
167,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
168,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
168,2,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
168,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
169,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
169,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
170,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
171,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
171,2,Bernard-Soulier syndrome,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
171,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
171,4,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
171,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
172,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
173,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
174,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
174,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
174,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
174,4,Retinal cyst,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
174,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
175,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
176,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
176,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
177,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
178,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
178,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
179,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
179,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
180,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
181,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
181,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
181,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
181,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
182,1,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
183,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
184,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
184,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
185,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
186,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
186,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
186,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
187,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
187,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
187,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
187,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
188,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
189,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
189,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
189,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
189,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
189,6,Walking distance test abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
190,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
190,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
190,4,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
191,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
192,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
192,2,Oesophageal food impaction,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
193,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
194,1,Cervix carcinoma stage I,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
195,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
195,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
196,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,1,Viral pericarditis,Viral infections NEC,Viral infectious disorders,Infec,N
198,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
199,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
200,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
201,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
201,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
202,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
203,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
203,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
204,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
204,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
205,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
206,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
207,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
207,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
208,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
209,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
209,2,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
209,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
210,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
211,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
212,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
213,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
213,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
213,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
213,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
213,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
213,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
213,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
213,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
214,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
214,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
214,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
214,4,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
214,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
214,6,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
214,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
214,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
215,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
215,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
216,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
217,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
217,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
217,3,Headache,Headaches NEC,Headaches,Nerv,N
217,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
218,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
219,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,2,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
219,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
220,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
220,2,Lymphomatoid papulosis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
220,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
221,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
222,1,Macular cyst,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
222,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
222,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
222,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
223,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
223,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
225,1,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
225,2,Headache,Headaches NEC,Headaches,Nerv,N
225,3,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
225,4,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
225,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
225,6,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
226,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
226,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
226,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
226,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
227,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
228,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
228,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
229,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
229,2,Dissociation,Dissociative states,Dissociative disorders,Psych,N
229,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
229,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
229,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
230,2,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
230,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
231,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
231,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
231,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
232,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
232,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
232,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
232,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
232,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
233,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
233,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
234,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
235,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
236,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
237,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
238,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
238,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
238,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
239,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
239,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
239,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
239,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,5,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
239,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
239,7,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
239,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
239,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
239,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
239,11,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
239,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
239,13,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
240,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
240,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
240,3,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
240,4,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
240,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
240,6,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
240,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
241,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
242,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
243,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
243,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
243,3,Cranial nerve paralysis,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
243,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
243,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
243,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
243,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
243,8,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
243,9,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
243,10,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
243,11,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
243,12,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
244,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
245,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
245,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
246,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
246,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
246,3,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
247,1,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
247,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
247,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
247,4,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
247,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
247,6,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
247,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
247,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
248,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
248,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
248,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
249,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
249,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
249,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
250,1,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
251,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
251,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
252,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
252,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
252,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
252,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
252,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
252,6,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
252,7,Headache,Headaches NEC,Headaches,Nerv,N
252,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
252,9,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
252,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
252,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
253,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
254,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
255,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
255,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
255,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
255,4,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
255,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
256,1,Lymphomatoid papulosis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
256,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
256,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
256,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
257,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
258,1,Hypercoagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
259,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
259,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
260,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
261,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
262,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
263,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
264,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
265,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
265,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
266,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
267,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
268,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
268,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
268,3,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
268,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
268,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
268,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
269,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
269,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
269,3,Skin fibrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
269,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
270,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
271,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
271,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
271,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
271,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
272,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
272,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
273,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
274,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
275,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
276,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
276,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
277,1,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
277,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
277,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
277,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
277,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
277,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
278,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
279,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
279,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
280,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
281,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
282,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
283,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
285,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
286,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
286,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
286,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
287,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
288,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
288,2,Headache,Headaches NEC,Headaches,Nerv,N
289,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
290,1,Cataract cortical,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
291,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
292,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
292,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
293,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
293,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
293,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
293,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
293,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
294,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
294,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
295,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
295,3,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
295,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,5,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
295,6,Hepatobiliary cancer,Hepatobiliary neoplasms malignant NEC,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
295,7,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
295,8,Malignant neoplasm of unknown primary site,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
295,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
295,10,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
295,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
296,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
296,2,Headache,Headaches NEC,Headaches,Nerv,N
296,3,Migraine,Migraine headaches,Headaches,Nerv,N
296,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
297,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
298,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
299,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
300,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
301,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
302,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
303,1,Metastatic gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
304,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
305,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
305,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
305,3,Tension headache,Headaches NEC,Headaches,Nerv,N
306,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
307,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
308,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
309,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
310,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
311,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
311,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
311,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
312,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
313,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
313,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
314,1,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
315,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
315,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
315,3,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
316,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
317,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
318,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
319,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
320,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
320,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
320,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
320,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
320,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
320,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
320,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
320,8,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
320,9,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
321,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
322,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
322,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
323,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
323,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
323,3,Pleurisy viral,Viral infections NEC,Viral infectious disorders,Infec,N
324,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
324,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
324,3,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
325,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
326,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
326,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
328,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
328,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
329,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
330,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
331,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
331,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
332,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
332,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
333,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
333,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
335,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
335,2,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
336,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
336,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
336,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
336,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
336,5,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
336,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
336,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
337,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
337,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
337,3,Nephritis,Nephritis NEC,Nephropathies,Renal,N
337,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
337,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
338,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
338,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
339,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
339,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
340,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
340,2,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
340,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
341,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
342,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
343,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
343,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
343,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
344,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
345,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
346,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
347,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
348,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
349,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
350,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
351,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
352,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
352,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
353,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
353,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
353,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
353,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
353,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
353,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
354,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
354,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
354,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
354,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
355,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
356,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
357,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
357,2,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
357,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
357,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
357,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
357,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
357,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
357,8,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
357,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
357,10,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
357,11,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
357,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
357,13,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
358,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
358,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
359,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
359,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
361,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
361,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
361,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
361,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
361,5,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
361,6,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
361,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
361,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
361,9,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
361,10,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
361,11,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
362,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
362,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
363,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
364,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
364,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
365,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,1,Tumefactive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
367,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
368,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
368,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
369,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
370,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
371,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
372,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
373,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
374,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
374,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
375,1,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
376,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
377,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
378,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
378,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
379,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
379,2,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
380,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
381,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
382,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
383,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
384,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
384,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
385,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
385,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
385,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
386,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
387,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
388,1,Vulvovaginal warts,Vaginal neoplasms benign,Reproductive neoplasms female benign,Neopl,N
389,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
389,2,Migraine,Migraine headaches,Headaches,Nerv,N
389,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
389,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
390,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
391,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
392,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
392,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
392,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
393,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
393,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
394,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
395,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
396,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
396,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
396,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
396,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
396,5,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
396,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
396,7,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
397,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
397,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
398,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
399,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
400,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
400,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
401,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
401,2,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
401,3,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
401,4,Herpes zoster cutaneous disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
401,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
401,6,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
402,1,Headache,Headaches NEC,Headaches,Nerv,N
402,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
403,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
403,2,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
403,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
404,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
404,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
405,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
405,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
405,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
406,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
406,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
406,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
407,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
407,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
407,3,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
408,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
409,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
409,2,Muscle oedema,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
410,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
411,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
412,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
412,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
412,3,Headache,Headaches NEC,Headaches,Nerv,N
412,4,Migraine,Migraine headaches,Headaches,Nerv,N
413,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
414,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
415,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
416,1,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
417,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
418,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
419,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
420,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
420,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
421,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
422,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
423,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
424,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
425,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
425,2,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
425,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
425,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
425,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
426,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
427,1,Headache,Headaches NEC,Headaches,Nerv,N
427,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
428,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
429,1,Ehlers-Danlos syndrome,Connective tissue disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
430,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
430,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
431,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
431,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
432,1,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
433,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
433,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
433,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
433,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
434,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
435,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
436,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
437,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
438,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
438,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
439,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
440,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
441,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
442,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
442,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
442,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
442,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
443,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
443,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
444,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
445,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
446,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
446,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
447,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
447,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
448,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
448,2,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
449,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
450,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
450,2,Nasal injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
450,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
451,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
451,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
452,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
453,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
453,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
454,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
455,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
456,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
456,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
456,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
456,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
456,5,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
457,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
458,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
458,2,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
459,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
460,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
460,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
460,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
462,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
463,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
463,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
463,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
464,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
464,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
465,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
465,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
465,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
465,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,6,Stasis dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
466,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
467,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
468,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
468,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
469,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
469,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
470,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
471,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
472,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
472,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
473,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
473,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
473,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
474,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
475,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
475,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
475,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
476,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
476,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
477,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
478,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
478,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
479,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
479,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
480,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
481,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
482,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
482,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
482,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
482,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
482,5,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
482,6,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
482,7,Volume blood decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
483,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
484,1,Non-small cell lung cancer stage I,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
485,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
485,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
485,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
485,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
485,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,6,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
485,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
486,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
488,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
489,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
490,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
491,1,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
492,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
493,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
494,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
495,1,Ventricular tachyarrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
496,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
497,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
497,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
498,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
498,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
500,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
501,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
502,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
502,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
503,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
504,1,Laryngeal papilloma,Pharyngeal and laryngeal neoplasms benign,Respiratory and mediastinal neoplasms benign (excl mesotheliomas),Neopl,N
505,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
506,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
506,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
506,3,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
506,4,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
506,5,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
506,6,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
507,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
507,2,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
507,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
508,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
509,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
509,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
509,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
509,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
509,6,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
510,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
510,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
510,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
510,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
511,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
511,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
512,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
512,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
513,1,Human papilloma virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
514,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
515,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
515,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
515,3,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
516,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
516,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,3,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
517,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
518,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
519,1,Rectal neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
520,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
520,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
521,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
522,1,Amniotic fluid volume decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
522,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
522,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
523,1,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
523,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
524,1,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
524,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
525,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
526,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
527,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
527,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
528,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
528,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
529,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
529,2,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
529,3,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
529,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
529,6,Limb deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
529,7,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
529,8,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
529,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
529,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
529,11,Sphincter of Oddi dysfunction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
530,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
530,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
530,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
531,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
532,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
532,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
533,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
534,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
534,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
534,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
534,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
534,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
534,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
534,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
535,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
535,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
536,1,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
536,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
537,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
538,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
539,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
540,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
540,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
541,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
542,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
543,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
544,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
545,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
546,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
547,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
548,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
549,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
550,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
551,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
552,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
552,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
552,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
552,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
552,6,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
552,7,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
552,8,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
552,9,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
552,10,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
552,11,Teething,Dental disorders NEC,Dental and gingival conditions,Gastr,N
552,12,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
553,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
554,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
554,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
554,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,4,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
555,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
555,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
555,3,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
555,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
556,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
557,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
558,1,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
559,1,Tumefactive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
560,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
560,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
561,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
562,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
562,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
563,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
563,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
564,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
564,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
564,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
566,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
566,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
566,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
566,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
567,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
568,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
568,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
568,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
568,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
568,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
568,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
569,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
570,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
570,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
571,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
572,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
572,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
573,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
573,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
573,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
573,4,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
573,5,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
573,6,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
573,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
573,8,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
573,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
573,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
574,1,Cervix carcinoma recurrent,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
575,1,Expanded disability status scale score increased,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
575,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
575,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
576,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
577,1,Expanded disability status scale score increased,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
577,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
577,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
578,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
579,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
579,2,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
580,1,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
581,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
582,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
583,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
584,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
585,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
586,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
587,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
587,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
587,4,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
587,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
588,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
588,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
588,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
588,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
588,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
588,6,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
588,7,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,8,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
589,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
590,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
591,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
591,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
592,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
593,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
594,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
594,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
595,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
595,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
597,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
598,1,Chronic hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
598,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
599,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
599,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
599,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
599,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
601,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
602,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
603,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
604,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
605,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
605,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
606,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
606,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
607,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
607,2,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
607,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
608,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
609,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
609,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
609,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
609,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
609,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
609,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
609,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
609,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
610,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
610,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
610,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
611,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
612,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
612,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
612,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
614,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
615,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
615,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
616,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
617,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
617,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
618,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
619,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
620,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
620,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
621,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
622,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
622,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
622,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
622,4,Headache,Headaches NEC,Headaches,Nerv,N
622,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
622,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
622,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
623,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
624,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
625,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
626,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
627,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
628,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
629,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
630,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
630,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
631,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
632,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
632,2,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
632,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
633,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
633,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
634,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
635,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
635,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
636,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
637,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
637,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
638,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
638,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
638,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
638,4,Migraine,Migraine headaches,Headaches,Nerv,N
638,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
639,1,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
639,2,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
640,1,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
640,2,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
641,1,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
641,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
641,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
642,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
642,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
642,3,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
642,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
642,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,6,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
643,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
644,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
644,2,Headache,Headaches NEC,Headaches,Nerv,N
644,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
644,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
645,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
646,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
647,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
647,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
647,3,Headache,Headaches NEC,Headaches,Nerv,N
647,4,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
647,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
648,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
649,1,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
650,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
650,2,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
651,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
651,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
652,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
652,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
652,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
653,1,Carotid artery dissection,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
653,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
654,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
654,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
654,4,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
654,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,6,Tumefactive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,Y
655,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
656,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
656,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
657,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
658,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
658,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
659,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
659,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
659,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
659,4,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
659,5,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
660,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
661,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
662,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
663,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
663,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
663,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
664,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
664,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
664,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
665,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
666,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
667,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
667,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
668,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
669,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
669,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
669,3,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
669,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
670,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
670,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
671,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
671,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
671,3,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
672,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
672,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
673,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
674,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
675,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
675,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
676,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
676,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
677,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
677,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
677,3,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
678,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
678,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
678,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
678,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
678,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
679,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
680,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
681,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
682,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
683,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
683,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
684,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
684,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
685,1,Rectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
686,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
687,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
687,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
688,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
689,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
689,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
689,3,Expanded disability status scale score increased,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
689,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
689,5,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
690,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
690,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
691,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
692,1,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
692,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
693,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
694,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
695,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
696,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
697,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
697,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
697,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
698,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
699,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
700,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
701,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
702,1,Headache,Headaches NEC,Headaches,Nerv,N
702,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
702,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
702,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
703,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
704,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
705,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
705,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
705,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
705,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
705,6,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
705,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
705,8,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
705,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
705,10,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
705,11,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
705,12,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
706,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
707,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
708,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
709,1,Headache,Headaches NEC,Headaches,Nerv,N
710,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
710,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
710,3,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
710,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
711,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
712,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
712,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
712,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
712,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
712,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
713,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
714,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
715,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
716,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
716,2,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
716,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
716,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
716,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
716,6,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
717,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
718,1,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
719,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
720,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
721,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
721,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
722,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
722,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
722,3,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
722,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
722,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
722,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
722,7,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
722,8,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
722,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
723,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
723,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
724,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
725,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
726,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
727,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
727,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
727,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
728,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
729,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
730,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
731,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,2,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
731,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
731,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
731,5,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
731,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
732,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
733,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
734,1,Headache,Headaches NEC,Headaches,Nerv,N
734,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
734,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
734,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
735,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
736,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
737,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
737,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
737,3,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
738,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
738,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
738,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
739,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
740,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
740,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
740,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
740,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
740,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
740,7,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
741,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
741,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
741,3,Headache,Headaches NEC,Headaches,Nerv,N
741,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
741,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
742,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
742,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
743,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
743,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
743,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
743,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
743,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
744,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
745,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
746,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
747,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
748,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
748,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
749,1,Primary biliary cholangitis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
750,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
751,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
752,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
753,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
754,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
755,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
756,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
756,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
756,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
756,4,Haemorrhagic infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
756,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
756,6,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
757,1,Smear cervix,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
758,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
759,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
760,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
761,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
761,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
762,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
764,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
765,1,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
766,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
766,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
767,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
767,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
768,1,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
768,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
769,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
770,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
770,2,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
771,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
772,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
773,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
774,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
775,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
775,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
776,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
777,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
778,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
779,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
779,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
780,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
781,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
781,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
782,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
783,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
783,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
783,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
784,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
784,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
785,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
785,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
786,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
787,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
788,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
789,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
789,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
790,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
791,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
792,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
793,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
793,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
794,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
795,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
795,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
795,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
796,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
797,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
798,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
799,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
800,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
801,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
802,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
802,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
803,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
803,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
804,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
805,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
806,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
807,1,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
807,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
807,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
808,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
809,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
810,1,Skin cancer metastatic,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
811,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
812,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
813,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
813,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
813,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
814,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
814,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
814,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
814,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,1,Papulopustular rosacea,Rosaceas,Skin appendage conditions,Skin,N
816,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
817,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
817,2,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
818,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
818,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
819,3,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
820,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
821,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
822,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
823,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
824,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
825,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
826,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
826,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
827,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
827,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
827,3,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
828,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
829,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
829,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
829,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
830,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
830,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
831,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
831,2,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
832,1,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
833,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
834,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
834,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
835,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
835,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
835,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
836,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
836,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
837,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
837,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
838,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
838,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
839,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
840,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
841,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
842,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
843,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
843,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
843,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
844,1,Vulval cancer,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
845,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
845,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
845,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
845,4,Thyroxine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
846,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
847,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
848,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
849,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
850,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
850,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
851,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
852,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
853,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
853,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
853,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
854,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
855,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
856,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
857,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
858,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
860,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
860,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
860,3,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
860,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
861,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
862,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
863,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
864,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
865,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
866,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
867,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
868,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
869,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
870,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
871,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
872,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
872,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
873,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
873,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
873,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
873,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
873,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
873,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
874,1,Osseous cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
875,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
876,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
877,1,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
878,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
879,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
880,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
881,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
881,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
882,1,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
883,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
884,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
884,2,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
884,3,Sensory processing disorder,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
884,4,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
884,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
885,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
886,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
887,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
888,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
889,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
890,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
891,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
891,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,1,Cryptococcal meningoencephalitis,Cryptococcal infections,Fungal infectious disorders,Infec,N
893,1,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
